跳转至内容
Merck

860480P

Avanti

C10 bisphosphonate

Avanti Polar Lipids 860480P, powder

别名:

1-aminodecane-1,1-bisphosphonic acid

登录查看公司和协议定价


About This Item

经验公式(希尔记法):
C10H25NO6P2
CAS号:
分子量:
317.26
分類程式碼代碼:
12352211
NACRES:
NA.25

形狀

powder

包裝

pkg of 1 × 500 μg (860480P-500ug)

製造商/商標名

Avanti Polar Lipids 860480P

脂質類型

bioactive lipids
sphingolipids

運輸包裝

dry ice

儲存溫度

−20°C

SMILES 字串

[NH3+]C(P([O-])(O)=O)(P(O)(O)=O)CCCCCCCCC

應用

C10 bisphosphonate is suitable for use as an inhibitor for acid sphingomyelinase.

生化/生理作用

C10 bisphosphonate, with prolonged carbon chain, is an inhibitor for acid sphingomyelinase and may be a treatment option for inflammatory lung diseases, cystic fibrosis and atherosclerosis. It interacts with the divalent metal ions and forms bidentate complexes. Bisphosphonates are inhibitors of end reaction in pathways. It is an inhibitor of cytosolic farnesyl diphosphate (FDP) synthase (geranyl diphosphate (GDP) and geranylgeranyl diphosphate (GGDP) synthase and isoprene pathway. Bisphosphonates have antimicrobial functionality and inhibits the growth of Entamoeba histolytica and Plasmodium falciparum.

包裝

5 mL Amber Glass Screw Cap Vial (860480P-500ug)

法律資訊

Avanti Research is a trademark of Avanti Polar Lipids, LLC

儲存類別代碼

11 - Combustible Solids

水污染物質分類(WGK)

WGK 3


分析证书(COA)

输入产品批号来搜索 分析证书(COA) 。批号可以在产品标签上"批“ (Lot或Batch)字后找到。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

Acid sphingomyelinase promotes mitochondrial dysfunction due to glutamate-induced regulated necrosis
Novgorodov SA, et al.
Journal of Lipid Research, 59(2), 312-329 (2018)
Potent and selective inhibition of acid sphingomyelinase by bisphosphonates
Roth AG, et al.
Angewandte Chemie (International Edition in English), 48(41), 7560-7563 (2009)
Bisphosphonate inhibitors reveal a large elasticity of plastidic isoprenoid synthesis pathway in isoprene-emitting hybrid aspen
Rasulov B, et al.
Plant Physiology, 168(2), 532-548 (2015)
Effects of bisphosphonates on the growth of Entamoeba histolytica and Plasmodium species in vitro and in vivo
Ghosh S, et al.
Journal of Medicinal Chemistry, 47(1), 175-187 (2004)
Volker Teichgräber et al.
Nature medicine, 14(4), 382-391 (2008-04-01)
Microbial lung infections are the major cause of morbidity and mortality in the hereditary metabolic disorder cystic fibrosis, yet the molecular mechanisms leading from the mutation of cystic fibrosis transmembrane conductance regulator (CFTR) to lung infection are still unclear. Here

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门